Viral gene delivery vectors: the next generation medicines for immune-related diseases

被引:17
|
作者
De Haan, Peter [1 ]
Van Diemen, Ferdy R. [1 ]
Toscano, Miguel G. [2 ]
机构
[1] Amarna Therapeut BV, Dept R&D, Leiden, Netherlands
[2] Amarna Therapeut SL, Dept R&D, Seville, Spain
关键词
Immune system; immune tolerance; self-antigen; vaccine; cancer; autoimmune disease; alphavirus; sv40; adeno-associated virus; lentivirus; viral vector; gene therapy; immunotherapy; tolerization; AUTOIMMUNE-DISEASES; CANCER; TOLERANCE; SELF; RECEPTOR; THERAPY; IMMUNOTHERAPY; INFLAMMATION; VACCINATION; ANTIBODIES;
D O I
10.1080/21645515.2020.1757989
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Viruses have evolved to efficiently express their genes in host cells, which makes them ideally suited as gene delivery vectors for gene and immunotherapies. Replication competent (RC) viral vectors encoding foreign or self-proteins induce strong T-cell responses that can be used for the development of effective cancer treatments. Replication-defective (RD) viral vectors encoding self-proteins are non-immunogenic when introduced in a host naive for the cognate virus. RD viral vectors can be used to develop gene replacement therapies for genetic disorders and tolerization therapies for autoimmune diseases and allergies. Degenerative/inflammatory diseases are associated with chronic inflammation and immune responses that damage the tissues involved. These diseases therefore strongly resemble autoimmune diseases. This review deals with the use of RC and RD viral vectors for unraveling the pathogenesis of immune-related diseases and their application to the development of the next generation prophylactics and therapeutics for todays' major diseases.
引用
收藏
页码:14 / 21
页数:8
相关论文
共 50 条
  • [41] Emerging non-viral vectors for gene delivery
    Chenfei Wang
    Chaolan Pan
    Haiyang Yong
    Feifei Wang
    Tao Bo
    Yitong Zhao
    Bin Ma
    Wei He
    Ming Li
    Journal of Nanobiotechnology, 21
  • [42] Engineering viral vectors for acoustically targeted gene delivery
    Li, Hongyi R.
    Harb, Manwal
    Heath, John E.
    Trippett, James S.
    Shapiro, Mikhail G.
    Szablowski, Jerzy O.
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [43] Engineering Viral Vectors for Acoustically Targeted Gene Delivery
    Li, Hongyi
    MOLECULAR THERAPY, 2022, 30 (04) : 84 - 85
  • [44] Viral vectors for gene delivery to the central nervous system
    Lentz, Thomas B.
    Gray, Steven J.
    Samulski, R. Jude
    NEUROBIOLOGY OF DISEASE, 2012, 48 (02) : 179 - 188
  • [45] Nanoparticles as Non-Viral Gene Delivery Vectors
    Katragadda, Chinmayee Sarita
    Choudhury, Prasanta Kumar
    Murthy, P. N.
    INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH, 2010, 44 (02) : 109 - 120
  • [46] Next Generation of Adeno-Associated Virus Vectors for Gene Therapy for Human Liver Diseases
    Berns, Kenneth I.
    Srivastava, Arun
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2019, 48 (02) : 319 - +
  • [47] Viral vectors and delivery strategies for CNS gene therapy
    Gray, Steven J.
    Woodard, Kenton T.
    Samulski, R. Jude
    THERAPEUTIC DELIVERY, 2010, 1 (04) : 517 - 534
  • [48] Biopolymers augment viral vectors based gene delivery
    Balaji Balakrishnan
    Ernest David
    Journal of Biosciences, 2019, 44
  • [49] Emerging non-viral vectors for gene delivery
    Wang, Chenfei
    Pan, Chaolan
    Yong, Haiyang
    Wang, Feifei
    Bo, Tao
    Zhao, Yitong
    Ma, Bin
    He, Wei
    Li, Ming
    JOURNAL OF NANOBIOTECHNOLOGY, 2023, 21 (01)
  • [50] Viral Vectors for Gene Delivery to Corneal Endothelial Cells
    Fuchsluger, T. A.
    Jurkunas, U.
    Kazlauskas, A.
    Dana, R.
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2011, 228 (06) : 498 - 503